文献速递垂体与肾上腺疾病骨质疏松与钙磷/甲状旁腺

嗜铬细胞瘤患者骨量降低且骨吸收增高:交感神经活动对人类骨骼的重要性

Lower Bone Mass and Higher Bone Resorption in Pheochromocytoma: Importance of Sympathetic Activity on Human Bone.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

在620例新诊断肾上腺偶发瘤患者中,31例经组织学确诊的嗜铬细胞瘤患者与280例无功能肾上腺偶发瘤患者分别作为病例组和对照组。校正混杂因素后,嗜铬细胞瘤患者腰椎骨量降低7.2%、血清1型胶原C端端肽(CTX)升高33.5%(P=0.016和0.001),股骨颈和全髋骨密度及血清骨特异性碱性磷酸酶(BSALP)无统计学差异。嗜铬细胞瘤患者腰椎低骨密度的OR为3.31(95%CI 1.23-8.56),肾上腺切除术后血清CTX降低35.2%,BSALP无显著变化。

要点

  • 嗜铬细胞瘤患者腰椎骨量较无功能肾上腺偶发瘤患者降低7.2%(P=0.016)。
  • 嗜铬细胞瘤患者血清CTX较无功能肾上腺偶发瘤患者升高33.5%(P=0.001)。
  • 肾上腺切除术后嗜铬细胞瘤患者血清CTX降低35.2%,BSALP无显著变化。

核心结论

  • 嗜铬细胞瘤中的交感神经过度刺激可通过增加骨丢失(尤其是小梁骨)及骨吸收对人类骨骼产生不良影响。

研究设计与样本

  • 在620例连续的新诊断肾上腺偶发瘤受试者中,31例经组织学确诊的嗜铬细胞瘤患者为病例组,280例无功能肾上腺偶发瘤患者为对照组。

主要发现

  • 校正混杂因素后,嗜铬细胞瘤患者腰椎骨量较无嗜铬细胞瘤者低7.2%(P=0.016),血清CTX高33.5%(P=0.001)。
  • 股骨颈和全髋骨密度及血清BSALP水平在两组间无统计学差异。
  • 嗜铬细胞瘤患者腰椎低骨密度的OR为3.31(95%CI 1.23-8.56)。
  • 股骨颈和全髋低骨密度的OR在有无嗜铬细胞瘤者间无差异。
  • 嗜铬细胞瘤患者肾上腺切除术后血清CTX降低35.2%,血清BSALP无显著变化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Despite the apparent biological importance of sympathetic activity on bone metabolism in rodents, its role in humans remains questionable. OBJECTIVE: To clarify the link between the sympathetic nervous system and the skeleton in humans. DESIGN, SETTING, AND PATIENTS: Among 620 consecutive subjects with newly diagnosed adrenal incidentaloma, 31 patients with histologically confirmed pheochromocytoma (a catecholamine-secreting neuroendocrine tumor) and 280 patients with nonfunctional adrenal incidentaloma were defined as cases and controls, respectively. RESULTS: After adjustment for confounders, subjects with pheochromocytoma had 7.2% lower bone mass at the lumbar spine and 33.5% higher serum C-terminal telopeptide of type 1 collagen (CTX) than those without pheochromocytoma (P = 0.016 and 0.001, respectively), whereas there were no statistical differences between groups in bone mineral density (BMD) at the femur neck and total hip and in serum bone-specific alkaline phosphatase (BSALP) level. The odds ratio (OR) for lower BMD at the lumbar spine in the presence of pheochromocytoma was 3.31 (95% confidence interval, 1.23 to 8.56). However, the ORs for lower BMD at the femur neck and total hip did not differ according to the presence of pheochromocytoma. Serum CTX level decreased by 35.2% after adrenalectomy in patients with pheochromocytoma, whereas serum BSALP level did not change significantly. CONCLUSIONS: This study provides clinical evidence showing that sympathetic overstimulation in pheochromocytoma can contribute to adverse effects on human bone through the increase of bone loss (especially in trabecular bone), as well as bone resorption.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kim BJ, Kwak MK, Ahn SH, et al. Lower Bone Mass and Higher Bone Resorption in Pheochromocytoma: Importance of Sympathetic Activity on Human Bone. J Clin Endocrinol Metab. 2017. PMID: 28582552. doi:10.1210/jc.2017-00169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。